Pleiotropic actions of iron balance in diabetes mellitus

[1]  A. Skalny,et al.  Mutual interaction between iron homeostasis and obesity pathogenesis. , 2015, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[2]  M. Marsella,et al.  Transfusional iron overload and iron chelation therapy in thalassemia major and sickle cell disease. , 2014, Hematology/oncology clinics of North America.

[3]  O. Wagner,et al.  Heme Oxygenase-1 Drives Metaflammation and Insulin Resistance in Mouse and Man , 2014, Cell.

[4]  B. Thorand,et al.  Association of iron indices and type 2 diabetes: a meta‐analysis of observational studies , 2014, Diabetes/metabolism research and reviews.

[5]  G. Rutter,et al.  Hypoxia lowers SLC30A8/ZnT8 expression and free cytosolic Zn2+ in pancreatic beta cells , 2014, Diabetologia.

[6]  James E. Nelson,et al.  Serum ferritin is associated with non-alcoholic fatty liver disease and decreased Β-cell function in non-diabetic men and women. , 2014, Journal of diabetes and its complications.

[7]  K. He,et al.  Dietary iron intake and body iron stores are associated with risk of coronary heart disease in a meta-analysis of prospective cohort studies. , 2014, The Journal of nutrition.

[8]  J. Yun,et al.  Glutathione peroxidase mimic ebselen improves glucose-stimulated insulin secretion in murine islets. , 2014, Antioxidants & redox signaling.

[9]  Ying Cui,et al.  Cobalt Protoporphyrin Induces HO-1 Expression Mediated Partially by FOXO1 and Reduces Mitochondria-Derived Reactive Oxygen Species Production , 2013, PloS one.

[10]  M. Martínez-González,et al.  Association between Serum Ferritin and Osteocalcin as a Potential Mechanism Explaining the Iron-Induced Insulin Resistance , 2013, PloS one.

[11]  V. De Sanctis,et al.  Iron overload and glucose metabolism in subjects with β-thalassaemia major: an overview. , 2013, Current diabetes reviews.

[12]  J. Walley,et al.  Ferritin levels and risk of type 2 diabetes mellitus: an updated systematic review and meta‐analysis of prospective evidence , 2013, Diabetes/metabolism research and reviews.

[13]  J. Philippé,et al.  Ferroportin Q248H mutation, hyperferritinemia and atypical type 2 diabetes mellitus in South Kivu. , 2013, Diabetes & metabolic syndrome.

[14]  L. Boros,et al.  Iron regulates glucose homeostasis in liver and muscle via AMP‐activated protein kinase in mice , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  D. McClain,et al.  Iron and diabetes risk. , 2013, Cell metabolism.

[16]  J. Olefsky,et al.  The Origins and Drivers of Insulin Resistance , 2013, Cell.

[17]  A. Chawla,et al.  Pleiotropic Actions of Insulin Resistance and Inflammation in Metabolic Homeostasis , 2013, Science.

[18]  A. Stadlmayr,et al.  Glucose acts as a regulator of serum iron by increasing serum hepcidin concentrations. , 2013, The Journal of nutritional biochemistry.

[19]  Wei Bao,et al.  Dietary iron intake, body iron stores, and the risk of type 2 diabetes: a systematic review and meta-analysis , 2012, BMC Medicine.

[20]  Carol Wilson.  Obesity: Sugar-sweetened beverages—fueling the epidemic of childhood obesity? , 2012, Nature Reviews Endocrinology.

[21]  N. Andrews,et al.  Divalent metal transporter 1 regulates iron-mediated ROS and pancreatic β cell fate in response to cytokines. , 2012, Cell metabolism.

[22]  Carol Wilson.  Metabolism: Iron metabolism, adiponectin and T2DM—the link with adipocyte insulin resistance , 2012, Nature Reviews Endocrinology.

[23]  S. Hunt,et al.  Adipocyte iron regulates adiponectin and insulin sensitivity. , 2012, The Journal of clinical investigation.

[24]  H. Tian,et al.  Body Iron Stores and Heme-Iron Intake in Relation to Risk of Type 2 Diabetes: A Systematic Review and Meta-Analysis , 2012, PloS one.

[25]  J. Manson,et al.  Genetic Determinants for Body Iron Store and Type 2 Diabetes Risk in US Men and Women , 2012, PloS one.

[26]  F. Ashcroft,et al.  Diabetes Mellitus and the β Cell: The Last Ten Years , 2012, Cell.

[27]  Xu Lin,et al.  Association of TMPRSS6 polymorphisms with ferritin, hemoglobin, and type 2 diabetes risk in a Chinese Han population. , 2012, The American journal of clinical nutrition.

[28]  Elizabeta Nemeth,et al.  Rethinking iron regulation and assessment in iron deficiency, anemia of chronic disease, and obesity: introducing hepcidin. , 2012, Journal of the Academy of Nutrition and Dietetics.

[29]  Hoi Lun Cheng,et al.  The relationship between obesity and hypoferraemia in adults: a systematic review , 2012, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[30]  J. Moreno-Navarrete,et al.  Total and undercarboxylated osteocalcin predict changes in insulin sensitivity and β cell function in elderly men at high cardiovascular risk. , 2012, The American journal of clinical nutrition.

[31]  A. Bissery,et al.  Anemia normalization in patients with type 2 diabetes and chronic kidney disease: results of the NEPHRODIAB2 randomized trial. , 2011, Journal of diabetes and its complications.

[32]  C. Borgna-Pignatti,et al.  Complications of thalassemia major and their treatment , 2011, Expert review of hematology.

[33]  T. Coates,et al.  Iron chelation in thalassemia: time to reconsider our comfort zones , 2011, Expert review of hematology.

[34]  G. Kollias,et al.  A new role for myeloid HO-1 in the innate to adaptive crosstalk and immune homeostasis. , 2011, Advances in experimental medicine and biology.

[35]  L. Rodella,et al.  Adipocyte Heme Oxygenase-1 Induction Attenuates Metabolic Syndrome in Both Male and Female Obese Mice , 2010, Hypertension.

[36]  O. Blin,et al.  Orphandev, French Clinical Trials Network dedicated to Orphan drugs and therapeutics development for rare diseases , 2010, Orphanet Journal of Rare Diseases.

[37]  M. Zimmermann,et al.  Does obesity increase risk for iron deficiency? A review of the literature and the potential mechanisms. , 2010, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[38]  Bai Luo,et al.  Iron Overload and Diabetes Risk: A Shift From Glucose to Fatty Acid Oxidation and Increased Hepatic Glucose Production in a Mouse Model of Hereditary Hemochromatosis , 2010, Diabetes.

[39]  W. Bao,et al.  Association between heme oxygenase-1 gene promoter polymorphisms and type 2 diabetes mellitus: a HuGE review and meta-analysis. , 2010, American journal of epidemiology.

[40]  H. Forman.  Reactive oxygen species and α,β‐unsaturated aldehydes as second messengers in signal transduction , 2010, Annals of the New York Academy of Sciences.

[41]  J. Moreno-Navarrete,et al.  Transferrin receptor‐1 gene polymorphisms are associated with type 2 diabetes , 2010, European journal of clinical investigation.

[42]  Andrew V Biankin,et al.  Hypoxia-inducible factor-1alpha regulates beta cell function in mouse and human islets. , 2010, The Journal of clinical investigation.

[43]  Michael Boutros,et al.  SMAD7 controls iron metabolism as a potent inhibitor of hepcidin expression. , 2010, Blood.

[44]  R. Simó,et al.  Iron in obesity. An ancient micronutrient for a modern disease , 2010, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[45]  C. Scudamore,et al.  Human hephaestin expression is not limited to enterocytes of the gastrointestinal tract but is also found in the antrum, the enteric nervous system, and pancreatic {beta}-cells. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[46]  F. Trachtenberg,et al.  Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America , 2009, British journal of haematology.

[47]  S. Tam,et al.  Iron supplement in pregnancy and development of gestational diabetes—a randomised placebo‐controlled trial , 2009, BJOG : an international journal of obstetrics and gynaecology.

[48]  A. Negassa,et al.  Biomarkers of body iron stores and risk of developing type 2 diabetes , 2009, Diabetes, obesity & metabolism.

[49]  V. Positano,et al.  Heme Oxygenase-1 Induction Remodels Adipose Tissue and Improves Insulin Sensitivity in Obesity-Induced Diabetic Rats , 2009, Hypertension.

[50]  Jerry Kaplan,et al.  The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. , 2008, Cell metabolism.

[51]  J. Olefsky,et al.  Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. , 2008, Cell Metabolism.

[52]  G. Ioannou,et al.  Is Obesity Associated With Anemia of Chronic Disease? A Population‐based Study , 2008, Obesity.

[53]  M. Murphy,et al.  Declining prevalence of diabetes mellitus in hereditary haemochromatosis--the result of earlier diagnosis. , 2008, Diabetes research and clinical practice.

[54]  H. Bonkovsky,et al.  Differential regulation of human ALAS1 mRNA and protein levels by heme and cobalt protoporphyrin , 2008, Molecular and Cellular Biochemistry.

[55]  W. Aronow,et al.  Treatment of Obese Diabetic Mice With a Heme Oxygenase Inducer Reduces Visceral and Subcutaneous Adiposity, Increases Adiponectin Levels, and Improves Insulin Sensitivity and Glucose Tolerance , 2008, Diabetes.

[56]  G. Karsenty,et al.  Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice , 2008, Proceedings of the National Academy of Sciences.

[57]  N. Abraham,et al.  Pharmacological and Clinical Aspects of Heme Oxygenase , 2008, Pharmacological Reviews.

[58]  R. Sladek,et al.  Minor contribution of SMAD7 and KLF10 variants to genetic susceptibility of type 2 diabetes. , 2007, Diabetes & metabolism.

[59]  B. Bacon,et al.  Effects of iron loading on muscle: genome-wide mRNA expression profiling in the mouse , 2007, BMC Genomics.

[60]  J. Sullivan.  Macrophage Iron, Hepcidin, and Atherosclerotic Plaque Stability , 2007, Experimental biology and medicine.

[61]  M. McKee,et al.  Endocrine Regulation of Energy Metabolism by the Skeleton , 2007, Cell.

[62]  M. Andersen,et al.  Reactive Oxygen Species as a Signal in Glucose-Stimulated Insulin Secretion , 2007, Diabetes.

[63]  A. Remaley,et al.  Inflammation and iron deficiency in the hypoferremia of obesity , 2007, International Journal of Obesity.

[64]  H. Bonkovsky,et al.  The FASEB Journal • FJ Express Full-Length Article Role of Bach1 and Nrf2 in up-regulation of the heme oxygenase-1 gene by cobalt protoporphyrin , 2022 .

[65]  R. Simó,et al.  Iron Deficiency in Obese Postmenopausal Women , 2006, Obesity.

[66]  A. Goldfine,et al.  Inflammation and insulin resistance. , 2006, The Journal of clinical investigation.

[67]  S. Heshka,et al.  Serum iron and body fat distribution in a multiethnic cohort of adults living in New York City. , 2006, Journal of the American Dietetic Association.

[68]  J. Manson,et al.  HFE genetic variability, body iron stores, and the risk of type 2 diabetes in U.S. women. , 2005, Diabetes.

[69]  R. Goebbels,et al.  The haemochromatotic human pancreas: a quantitative immunohistochemical and ultrastructural study , 2005, Diabetologia.

[70]  F. Ashcroft,et al.  Metabolic regulation of the pancreatic beta-cell ATP-sensitive K+ channel: a pas de deux. , 2004, Diabetes.

[71]  J. Halterman,et al.  Overweight children and adolescents: a risk group for iron deficiency. , 2004, Pediatrics.

[72]  Matthias W. Hentze,et al.  Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004 .

[73]  A. Cnaan,et al.  Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. , 2004, Haematologica.

[74]  W. Vogel,et al.  Distribution of DMT 1 within the human glandular system. , 2003, Histology and histopathology.

[75]  J. Cook,et al.  The quantitative assessment of body iron. , 2003, Blood.

[76]  P Lilos,et al.  Greater prevalence of iron deficiency in overweight and obese children and adolescents , 2003, International Journal of Obesity.

[77]  Y. Beguin,et al.  Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[78]  J. Fernández-Real,et al.  Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function. , 2002, Diabetes.

[79]  J. Koziol,et al.  Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA , 2002, The Lancet.

[80]  S. Abboud,et al.  A Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism* , 2000, The Journal of Biological Chemistry.

[81]  A. Brownlie,et al.  Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter , 2000, Nature.

[82]  R J Simpson,et al.  A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. , 2000, Molecular cell.

[83]  F. Facchini.  Effect of Phlebotomy on Plasma Glucose and Insulin Concentrations , 1998, Diabetes Care.

[84]  H. Lakka,et al.  Relation between iron stores and non-insulin dependent diabetes in men: case-control study , 1998, BMJ.

[85]  M. Hermans,et al.  Clinical aspects of diabetes secondary to idiopathic haemochromatosis in French-speaking Belgium. , 1997, Diabetes & metabolism.

[86]  S. Lenzen,et al.  Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. , 1996, Free radical biology & medicine.

[87]  W. Stremmel,et al.  Epidemiology, clinical spectrum and prognosis of hemochromatosis. , 1994, Advances in experimental medicine and biology.

[88]  J. Cook,et al.  Serum transferrin receptor. , 1993, Annual review of medicine.

[89]  J. Cook,et al.  Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia. , 1992, The Journal of laboratory and clinical medicine.

[90]  J. Cook,et al.  Serum transferrin receptor: a quantitative measure of tissue iron deficiency. , 1990, Blood.

[91]  B. Bagni,et al.  Alpha and beta cell evaluation in patients with thalassaemia intermedia and iron overload. , 1985, Postgraduate medical journal.

[92]  J. Nielsen,et al.  Liver-cell-membrane autoantibody specific for inflammatory liver diseases. , 1977, British medical journal.

[93]  D A Pyke,et al.  Observations on the pathogenesis, complications and treatment of diabetes in 115 cases of haemochromatosis. , 1972, The American journal of medicine.

[94]  C. Seltzer,et al.  SERUM IRON AND IRON-BINDING CAPACITY IN ADOLESCENTS. II. COMPARISON OF OBESE AND NONOBESE SUBJECTS. , 1963, The American journal of clinical nutrition.

[95]  C. Seltzer,et al.  SERUM IRON AND IRON-BINDING CAPACITY IN ADOLESCENTS. I. STANDARD VALUES. , 1963, The American journal of clinical nutrition.

[96]  J. Mayer,et al.  Hypoferraemia in obese adolescents. , 1962, Lancet.

[97]  S W Smith,et al.  A CASE OF HAEMOCHROMATOSIS , 1934, British medical journal.

[98]  E. Opie.  A CASE OF HAEMOCHROMATOSIS.-THE RELATION OF HAEMOCHROMATOSIS TO BRONZED DIABETES. , 1899 .